CIMI – Clinical Investigations & Medical Insights

Medical Insights & Engagement

Scientific strategy that strengthens communication and drives informed action.

Medical Affairs Strategy

  • Scientific platform and lexicon development
  • Cross-functional insight integration
  • Launch planning and lifecycle strategy
  • Strategic advisory board design and execution

Publication Planning

  • Peer-reviewed manuscripts (original research, clinical studies)
  • Review articles (narrative, systematic)
  • Scientific abstracts & posters
  • Congress presentation slides and speaker notes
  • Gap analysis and literature landscape reviews

Marketing Communications

  • Thought leadership white papers
  • Case studies and impact summaries
  • Branded and unbranded press releases
  • Social media content strategy (scientific tone of voice)

Education & Training

  • Scientific slide decks and speaker kits
  • Training manuals for field teams and investigators
  • eLearning modules and microlearning content
  • Workshop content and facilitation guides

Scientific Communications Planning

  • Integrated scientific communication plans (iSCPs) 
  • global-to-local messaging alignment
  • KPI tracking for communication impact
  • Coordination of cross-functional messaging

KOL Development & Engagement

  • Stakeholder mapping and engagement strategy
  • Scientific exchange frameworks and SOPs
  • KOL insight capture and analysis
  • Advisory board facilitation

Scientific Strategy & Advisory

  • Scientific positioning for AI-enabled/novel tech
  • Value communication strategy with HEOR/RWE integration
  • Benefit-risk communication and narrative development
  • Innovation workshops and internal alignment

Congress & Conference Strategy

  • Abstract and poster submission planning
  • Presentation and speaker support
  • Congress booth medical engagement planning
  • Real-time insight capture at global congresses

Regulatory Scientific Content

  • Clinical trial report (CSR) authoring and medical writing
  • Scientific content for regulatory submissions (510(k), PMA, IDE, De Novo, Post-Market Surveillance)
  • Labeling content development and review
  • Regulatory meeting prep and background information

Select Examples of Publications (Peer-Reviewed, Educational, Whitepapers)

• Levy, Y., Rempel, D., Nguyen, M., Yassine, A., Burns, M., Salgia, P., Lim, B., Butler, S., Berkeley, A., Bayram, E.
*The Fusion of Wide Field Optical Coherence Tomography & AI: Advancing Breast Cancer Surgical Margin Visualization.*
_Life_, 2023; 13(12): 2340.
🔗 [Read article](https://www.mdpi.com/2075-1729/13/12/2340)


• Hufnagel, R.B., Zimmerman (Butler), S.L., Krueger, L.A., et al.
A novel frontonasal dysplasia syndrome associated with deletion of the SIX2 gene.
American Journal of Medical Genetics Part A, 2016; 170(2): 487–491.
🔗 [Read article](https://doi.org/10.1002/art.39565)


• Liu, K., Kurien, B.T., Zimmerman (Butler), S.L., et al.
X chromosome dose and sex bias in autoimmune diseases: increased 47,XXX in SLE and Sjögren’s syndrome.
Arthritis & Rheumatology, 2016; 68(5): 1290–1300.
🔗 [Read article](https://doi.org/10.1177/0883073815575435)


• Hrabik, S.A., Standridge, S.M., Zimmerman (Butler), S.L., et al.
The clinical utility of a SNP microarray in patients with epilepsy at a tertiary medical center.
Journal of Child Neurology, 2015; 30(13): 1770–1777.
🔗 [Read article](https://doi.org/10.1177/0883073815575435)


• Rosenfeld, J.A., Zimmerman (Butler), S.L., et al.
Duplication of NSD1 causes growth retardation and microcephaly.
Molecular Syndromology, 2013; 3(6): 247–254.

🔗 [Read article](https://doi.org/10.1159/000346619)


• Sund, K., Zimmerman (Butler), S.L., et al.
Regions of homozygosity identified by SNP microarray analysis aid in the diagnosis of autosomal recessive disease.
Genetics in Medicine, 2013; 15(1): 70–80.

🔗 [Read article](https://doi.org/10.1038/gim.2012.115)


• George-Abraham, J.K., Zimmerman (Butler), S.L., et al.
Tetrasomy 15q25.2→qter identified by SNP microarray in a patient with multiple anomalies.
American Journal of Medical Genetics, 2012; 158A(8): 1971–1976.

🔗 [Read article](https://doi.org/10.1002/ajmg.a.35424)


• Myers, K., Zimmerman (Butler), S.L., et al.
The clinical phenotype of children with Fanconi anemia caused by biallelic BRCA2 mutations.
Pediatric Blood Cancer, 2012; 58(3): 462–465.

🔗 [Read article](https://doi.org/10.1002/pbc.23180)


• Sellars, E.A., Zimmerman (Butler), S.L., et al.
Ventricular noncompaction and absent thumbs in a newborn with tetrasomy 5q35.
American Journal of Medical Genetics, 2011; 155A(6): 1409–1413.

🔗 [Read article](https://doi.org/10.1002/ajmg.a.34040)


• Suzuki, T., Zimmerman (Butler), S.L., et al.
Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA.
The Journal of Experimental Medicine, 2008; 205(12): 2703–2710.

🔗 [Read article](https://doi.org/10.1084/jem.20081383)


Zimmerman (Butler), S.L. and Krane, C.M.
Molecular-genetic and functional analysis of aquaporins in vitro and in vivo.
Doctoral Dissertation, University of Dayton, 2007.


Zimmerman (Butler), S.L., Frisbie, J., Goldstein, D., et al.
Expression of aquaporins and glyceroporins during cold acclimation in Hyla chrysoscelis.
American Journal of Physiology, 2006; 292: R544–R555.

🔗 [Read article](https://doi.org/10.1152/ajpregu.00389.2005)


Select Whitepapers & Educational Publications

Next-generation sequencing (NGS): Revolutionizing patient care in your oncology practice.

Next-generation sequencing in pathology: Enabling personalized medicine.

Next-generation sequencing.